At a glance
ClinicalIndex Comparison RecordN/ACompleted· 192 enrolled
Drug / intervention
PEVAR (ProGlide closure) +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective, Multicenter, Randomized Controlled Trial of Endovascular Aneurysm Repair Using a Bilateral Percutaneous Approach (PEVAR) vs. Standard Approach (SEVAR) Using the IntuiTrak Endovascular AAA Delivery System and the Prostar XL or Perclose ProGlide Suture-Mediated Closure System
In Brief
A clinical study evaluating PEVAR (ProGlide closure), SEVAR (IntuiTrak), and 1 other intervention for Abdominal Aortic Aneurysm. Completed, enrolled 192 participants across 20 sites.
Detailed Summary
To determine the safety and effectiveness of PEVAR.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAbdominal Aortic Aneurysm
CountriesUnited States
CollaboratorsAbbott Medical Devices
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 2010
Enrollment StartApr 2010
Primary CompletionMar 2012
Study CompletionSep 2012
TodayJul 2026
First PostedFeb 17, 2010
Enrollment StartApr 13, 2010
Primary CompletionMar 9, 2012
Study CompletionSep 5, 2012
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 16.4 years ago
Interventions
PEVAR (ProGlide closure)device
Percutaneous EVAR facilitated by the ProGlide closure device
SEVAR (IntuiTrak)device
Standard vascular exposure for access prior to EVAR
PEVAR (Prostar XL closure)device
Percutaneous EVAR facilitated by the Prostar XL closure device